Lab Guide / Education

Understand your bloodwork

Choose a question for a plain-language answer about biomarkers, preparation, or the testing process.

Look up abbreviations

Browse questions

Tests and results

Preparation and ordering

Questions for your clinician

Educational guide

What does apolipoprotein B (ApoB) measure?

ApoB is a protein found on particles such as low-density lipoprotein (LDL) that carry cholesterol. An ApoB test measures how much of the protein is in a sample. A lipid panel reports cholesterol carried by different types of particles and also reports triglycerides.

American Heart Association · Apolipoprotein B View test details

Biomarker mechanisms and measurement

ApoB and arterial particle retention

Each circulating atherogenic lipoprotein particle carries one ApoB molecule. Routine ApoB testing typically reports protein mass concentration in mg/dL and serves as a proxy for particle number. LDL-C measures the mass of cholesterol carried in LDL. The two can differ because cholesterol content varies between particles.

Retention of ApoB-containing particles in the arterial wall can contribute to plaque formation. An ApoB and LDL-C comparison alone cannot identify the particle-size distribution.

National Lipid Association ApoB consensus

Cell-free DNA methylation

Blood contains cell-free DNA fragments from multiple tissues. Some multi-cancer detection tests look for patterns in chemical marks called methylation. A signal requires follow-up to determine its cause. A negative result cannot rule out cancer.

Read the screening and liquid biopsy guide · National Cancer Institute overview

Fasting insulin and HOMA1-IR

Insulin helps regulate blood glucose. When tissues respond less strongly to insulin, pancreatic beta cells can compensate by secreting more. HOMA1-IR uses fasting glucose and insulin as a model-based estimate. Interpretation depends on the assay and population.

With fasting glucose in mg/dL and insulin in µIU/mL, HOMA1-IR equals glucose × insulin ÷ 405. Review of insulin resistance measures

ApoB and HOMA1-IR scenarios

Explore how both values would change if the percentages you enter repeated each year. The defaults are illustrative assumptions. Negative percentages model a decrease.

Scenario assumptions After 5 years · ApoB 90.39 mg/dL · HOMA1-IR 1.85
Practice the calculations

These examples show the arithmetic. The TG/HDL-C ratio uses two mass concentrations in mg/dL. It cannot measure LDL particle size.

HOMA1-IR and QUICKI HOMA1-IR: 1.11 · QUICKI: 0.377
Estimated average glucose from HbA1c Estimated average glucose: 103 mg/dL

QUICKI formula · ADA HbA1c conversion

LDL-C change LDL-C change: −106 mg/dL (−81.5%)

In GLAGOV, researchers measured changes in coronary plaque using intravascular ultrasound. The calculator compares the two LDL-C readings. GLAGOV trial

hs-CRP change hs-CRP change: −0.6 mg/L (−50%)

CRP can rise with infection, injury, or other sources of inflammation. A change alone cannot identify the cause. MedlinePlus CRP guide

TG/HDL-C ratio TG/HDL-C ratio: 1.60

Cancer screening and liquid biopsy

Multi-cancer detection tests
These tests look for signals associated with several cancers. A signal requires follow-up to determine its cause. Continue recommended routine screening and discuss any additional testing with a clinician. Read the NCI guide to multi-cancer detection.
Post-treatment monitoring
In some cancer care settings, clinicians use circulating tumor DNA to help monitor treatment response. Ask the oncology team what the test can tell you in your specific situation. Read the NCI overview of liquid biopsy.

Support a family member’s decision

Ask if they want help making a list of questions or getting to an appointment. Let them choose whether to pursue testing and who may see their results.

Download family conversation worksheet

Your plan

Read full policy